Lactobacillus reuteri ATCC PTA 5289 and Maintained Normal Gum Function

• Orodispersible lozenges containing a combination of Lactobacillus reuteri DSM 17938 and Lactobacillus reuteri ATCC PTA 5289 and normal gum function: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006

  • 2020-03
  • EFSA Journal 18(3)
  • • D. Turck
    • J. Castenmiller
    • S. de Henauw
    • Karen Ildico Hirsch‐Ernst
    • J. Kearney
    • H. Knutsen
    • A. Maciuk
    • I. Mangelsdorf
    • H. Mcardle
    • A. Naska
    • C. Peláez
    • K. Pentieva
    • F. Thies
    • S. Tsabouri
    • M. Vinceti
    • J. Bresson
    • Yolanda Sanz
    • A. Siani

  • PubMed: 32874242
  • DOI: 10.2903/j.efsa.2020.6004

  3 Insights on

  • Maintained Normal Gum Function

  • Low evidence

  The Panel concludes that the evidence provided is insufficient to establish a cause and effect relationship between the consumption of orodispersible lozenges containing a combination of L. reuteri DSM 17938 and L. reuteri ATCC PTA 5289 and maintenance of normal gum function.

  Effect

  Neutral

  Effect size

  Small